The prevalence of antibodies against tetanus, diptheria and Bordetella pertussis in health care professionals;Prevalencia de anticuerpos frente a tetanos, difteria y Bordetella pertussis en profesionales sanitarios

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 17, Issue 3, 1999, Pages 135-137

  Ortega, Paloma ^c   Gil, Ángel ^d   Astasio, Paloma ^d   Domínguez, Vicente ^d   De Juanes, José Ramón ^a   Arrazola, Pilar ^a   González, Antonio ^b  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b Depto Medico de Pasteur Merieux MSD   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d NONE

Author keywords

Bordetella pertussis; Diphtheria; Seroprevalence; Tetanus

Indexed keywords

DIPHTHERIA ANTIBODY; DIPHTHERIA VACCINE; PERTUSSIS VACCINE; TETANUS ANTIBODY; TETANUS TOXOID; BACTERIUM ANTIBODY;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; DIPHTHERIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH CARE PERSONNEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; REVACCINATION; SEROCONVERSION; SEROPREVALENCE; TETANUS; TETANUS PROPHYLAXIS; BORDETELLA PERTUSSIS; IMMUNOLOGY;

ADULT; ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; DIPHTHERIA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH PERSONNEL; HUMANS; MALE; TETANUS;

EID: 0033087768     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Tello O, Pachón del Amo I. Epidemiología de la difteria en Europa. Bol Epidemiol Semanal 1995; 3: 233-236.
2. Centro Nacional de Epidemiología. Comentario epidemiológico de las enfermedades de declaración obligatoria (EDO) y sistema de información microbiológica (SIM). España, Año 1906. Bol Epidemiol Semanal 1997; 1: 1-6.
3. Comodo N, Bonnani P, Lo Nostro A, Tiscione E, Mannelli F, Tomei A. Low prevalence of diphtheria immunity in the population of Florence, Italy. Eur J Epidemiol 1996; 12: 251-255.
4. Bricarie F. Diphterie: a propos d'une epidemie. Press Medicale 1996; 25: 327-329.
5. Gergen PJ, McQuillan GM, Kiely M, Ezzati-Rice TM, Sutter RW, Virella G. A population-based serologic survey of immunity to tetanus in the United States. N Engl J Med 1995; 332: 761-766.
6. Cilla G, Sáenz-Dominguez JR, Montes M, Part C, Pérez-Trallero E. Inmunidad frente a tétanos en adultos mayores de 49 años. Med Clin (Barc) 1994; 103: 571-573.
7. Vidal J, Taberner JL, Plans P, Garrido P, Jiménez de Anta MT, Salleras L. Prevalencia de anticuerpos anticuerpos en la población adulta de Cataluña. Med Clin (Barc) 1992; 99: 6-8.
8. Gasparine R, Pozzi T, Fragapane E, Severini R, Cellesi C, Fabrizi P et al. Immunity to diphteria in Siena. Epidemiol Infect 1997; 119: 203-208.
9. Rey M, Vincent-Ballereau F, Patey O. The return of diphteria in Europe. Is the French population protected? Bull Acad Natl Med 1997; 181: 93-100.
10. Dal-Ré R, Arístegui J, Gil A, González A. Immunidad frente a la difteria en adultos jóvenes en España. Med Clin (Barc) 1995; 104: 676-677.
11. Gil A, Dal-Ré González A, Lasheras L, Aguilar L, Rey J. Inmunogenicidad y seguridad de una vacuna tétanos-difteria (tipo adulto), ensayo clínico en adultos. Med Clin (Barc) 1995; 104: 128-131.
12. Giammarco A, Chiarini A, Stroffolini T, De Mattia D, Chiaramonte M, Moschen ME. Seroepidemiology of Pertussis in Italy. Rev Infect Dis 1991; 13: 1.216-1.220.
13. Zackrisson G, Krantz I, Lagergard T, Larsson P, Sekura K, Sigurs N et al. Antibody response to pertussis toxin in patients with clinical pertussis measured by enzyme-linked immunosorbent assay. Eur J Clin Microbiol Infect Dis 1988; 7: 149-154.
14. Melville-Smith ME, Seagroatt VA, Watkins JT. A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera. J Biol Standard 1983; 11: 137-144.
15. Melville-Smith ME, Balfour A. Estimation of Corynebacterium diphtheriae antitoxin in human sera: a comparison of an enzyme-linked immunosorbent assay with, the toxin neutralization test. J Med Microbiol 1988; 25: 279-283.
16. II Encuesta de Serovigilancia de la Comunidad de Madrid. Documentos Técnicos de Salud Publica, n.o 29. Madrid: Dirección General de Prevención y Promoción de la Salud, 1995.
17. Yuan L, Lau W, Thipphawong J, Kasenda M, Xie F. Bevilacqua J. Diphtheria and tetanus immunity among blood donors in Toronto. Can Med Assoc J 1997; 156: 985-990.
18. Hasselhorn HM, Nübling M, Tiller FW, Hofmann F. Factors influencing immunity against diphtheria in adults. Vaccine 1998; 16: 70-75.
19. Diphtheria, tetanus and pertussis: Recommendations for vaccine use and other preventive mesures [editorial]. MMWR 1991; 40: 1-28.
20. American College of Physicians. Periodic health examinations: guide for designing health care in the asymptomatic patients. Medical practice Committee, American College of Physicians. An Intern Med 1981; 85: 729-732.
21. Canadian Task Force on the Periodic Health Examination. The periodic health examination. Can Med Assoc J 1979; 121: 1.193-1.254.
22. The US Preventive Services Task Froce. Guide to Clinical Preventive Services. An assessment of the effectiveness of 169 interventions. Baltimore: William and Wilkins, 1989.
23. Salleras L, Campins M, Martin D. Vacunación antidiftérica. En: Salleras Sanmarti L, editor. Vacunaciones preventivas. Principios y aplicaciones. Barcelona: Masson SA, 1997; 79-94.
24. Black S. Epidemiology of pertussis. Pediatr Infect Dis J 1997; 16: S85-89.
25. Nennig ME, Shinefield HR, Edwards KM, Black S, Fireman BH. Prevalence an incidence of adult pertussis in an urban population. JAMA 1996; 275: 1.672-1.674.
26. Baron S, Njamkepo E, Grimprel E. Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after routine use of vaccination. Pediatr Infect Dis J 1998; 17: 412-418.
27. Centers for Disease Control. Pertussis vaccination: use of acellularpertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1997; 46: 1-26.